Health
Funding will allow advancement of Nottingham COVID-19 vaccine to clinical trials – Mirage News
Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19. Experts…
Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19.
Experts from both universities are working with Scancell Holdings plc, a developer of novel immunotherapies for the treatment of cancer, to adapt its existing cancer vaccine platform for the development of a new vaccine.
Now, thanks to funding from Innovate UK, as part of UK Research and Innovation’s response to COVID-19, work can progress to Phase I cl…
Continue Reading
